search

Global Non-Hodgkin Lymphoma Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00 – $ 8,900.00

Non-Hodgkin Lymphoma Diagnostics Market By Type (Lymph Node Biopsy (Immunophenotyping, Cytogenetic Analysis, Gene Expression Profiling, Microarray analysis), (Physical Imaging (MRI Scanning, CT-Scan, X-rays, Fluorodeoxyglucose Positron Emission Tomography (FDG-PET), Blood Tests)), By Type of NHL (B-Cell Non-Hodgkin Lymphoma (Diffuse Large B-Cell Lymphoma, Burkitt Lymphoma, Mantel Cell Lymphoma, Primary Central Nervous System Lymphoma), (T-Cell Non-Hodgkin Lymphoma (Peripheral T-Cell Lymphoma not Otherwise Specified, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-Cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma, Adult T-Cell Lymphoma, Nasal type NK/T-Cell Lymphoma, Hepatosplenic T-Cell Lymphoma), By Category of Condition (Category A, Category B, Category X, Category E), By End User (Hospitals, Diagnostic Centers, Clinics), and Geography.

Request Sample

Request Methodology

Request Sample

$ PRICE - $ 3,000.00 – $ 8,900.00

Clear selection

SKU: N/A Categories: Healthcare, Medical Devices

Description
Table Of Content
Company Profile

Report

Description

Non-Hodgkin Lymphoma Diagnostics Market size was valued at USD 12149.12 million in 2021 and is expected to grow at a CAGR of 10.8% from 2022-2028. Non-Hodgkin’s lymphoma is a cancer which originates in lymphatic system. Non-Hodgkin’s lymphoma tumors develop from lymphocytes. It is more common than Hodgkin’s lymphoma. There are several type of non-Hodgkin lymphomas, among them follicular lymphoma ad Diffuse B-Cell lymphoma are most common subtypes. Symptoms may include painless swelling of limp nodes in neck, armpits or groin, abdominal pain, chest pain and others. Increasing prevalence of Non-Hodgkin’s lymphoma globally is one of the major factor which is attributing for the growth of the Non-Hodgkin lymphoma diagnostics market. According to Leukaemia and Lymphoma Society, NHL is the 7^th most common cancer in U.S and 5^th in UK. As per to the American cancer Society, 20150 deaths were recorded in U.S due to NHL in 2016.

Non-Hodgkin Lymphoma Diagnostics Market

MARKET SUMMARY

10.8% CAGR

Study Period– 2022 – 2028
Base Year– 2021
CAGR– 10.8%
Largest Market– North America
Fastest Growing Market– Asia Pacific

Non-Hodgkin Lymphoma Diagnostics Market

The report on the global Non-Hodgkin Lymphoma Diagnostics Market gives historical, current, and future market sizes (US$ Mn) on the basis of Type, Type of NHL, Category of Condition, End User and Geographical regions.
Global Non-Hodgkin Lymphoma Diagnostics Market gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.

Market Key Players

B-Cell Non-Hodgkin Lymphoma
Diffuse Large B-Cell Lymphoma
Burkitt Lymphoma
Mantel Cell Lymphoma
T-Cell Non-Hodgkin Lymphoma
Peripheral T-Cell Lymphoma not Otherwise Specified

Non-Hodgkin Lymphoma Diagnostics Market Drivers And Restraints

Growing awareness and concern about the disease, increase in healthcare expenditure, rise in advancements in the technologies and innovation of new products, large number of unmet needs related to the disease are the few factors which are propelling the growth of the Non-Hodgkin lymphoma diagnostics market. However, limited options for the treatment, inaccurate and inadequate results of the diagnosis, high cost associated with the tests are the few factors which are restraining the growth of the Non-Hodgkin lymphoma diagnostics market.

North-America got significant share

Non-Hodgkin Lymphoma Diagnostics Market

Geographically, Non-Hodgkin Lymphoma Diagnostics Market is segmented into North America, Europe, Asia Pacific, Latin America, and theMiddle East and Africa regions.North America dominates the global market for Non-Hodgkin Lymphoma Diagnostics market due to growing prevalence of Non-Hodgkin Lymphoma cases and technological advancements in the region, heavy investments in R & D activities along with government support will boost the industry demand over the coming years. The Europe market is anticipated to grow rapidly over the forecast timeline due to the rising occurrence of Non-Hodgkin Lymphoma along with increasing acceptance of gene technology. Asia is expected to witness high growth in Non-Hodgkin Lymphoma Diagnostics market, due to increasing government initiatives, rising economy, and improvement in healthcare infrastructure in the region.Some of the key driving forces for Non-Hodgkin Lymphoma Diagnostics market in emerging countries are increasing R&D investment, a large pool of patients and rising government funding.

Latin-America

North-America

Europe

Asia-Pacific

Middle East

Key

Key Features of the Report

The report provides granular level information about the market size, regional market share, historic market, and forecast.
The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments and startup’s details that are actively working in the market
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Non-Hodgkin Lymphoma Diagnostics Market Segmentation

Type

Lymph Node Biopsy
Immunophenotyping
Cytogenetic Analysis
Gene Expression Profiling
Microarray analysis
Physical Imaging
MRI Scanning
CT-Scan
X-rays
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
Blood Tests

Type of NHL

B-Cell Non-Hodgkin Lymphoma
Diffuse Large B-Cell Lymphoma
Burkitt Lymphoma
Mantel Cell Lymphoma
Primary Central Nervous System Lymphoma
T-Cell Non-Hodgkin Lymphoma
Peripheral T-Cell Lymphoma not Otherwise Specified
Anaplastic Large Cell Lymphoma
Angioimmunoblastic T-Cell Lymphoma
Enteropathy-Associated T-Cell Lymphoma
Adult T-Cell Lymphoma
Nasal type NK/T-Cell Lymphoma
Hepatosplenic T-Cell Lymphoma

Category-Condition

Category A
Category B
Category X
Category E

End User

Hospitals
Diagnostic Centers
Clinics

Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.